Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ajay Mehta, MS
Central India cancer Research Institute, Nagpur, India
Principal Investigator - Amol Bapaye, MS
Deenanath Mangeshkar Hospital & Research Centre, ,Pune, India
Principal Investigator - Anita Ramesh, MD
Sri RamaChandra Medical Centre, Chennai, India
Principal Investigator - J S Rajkumar, DNB
Lifeline Mutispecilaity Hospital, Chennai, India
Principal Investigator - Kirushna Kumar, MD
Meenakshi Mission Hospital & Reasearch Centre, Madurai, India
Principal Investigator - Raj Nagarkar, MS
Curie Manavata Cancer Centre, Nashik, India
Principal Investigator - Ravi K Saxena, DNB
Global Hospital, Hyderabad, India.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central India Cancer Research Institute
Nagpur, Ajayonco@hotmail.com, India
- Global Hospital
Hyderabaad, Andhra Pradesh, India
- Curie Manavata Cancer Centre
Nashik, Maharashtra, India
- Deenanath Mangeshkar Hospital & Research Centre
Pune, Maharashtra, India
- Lifeline Mutispecilaity Hospital
Chennai, Tamil Nadu, India
- Sri Ramachandra Medical Centre
Chennai, Tamil Nadu, India
- Meenakshi Mission Hospital & Reasearch Centre
Madurai, Tamil Nadu, India
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2009
- Primary completion
- 31 Dec 2010
- Completion
- —
- Last update posted
- 20 Jan 2012
- Registered enrollment
- 23
- Registry id
- NCT00898287
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.